Searched for
WOCKHARDT KHORAKIWALAS
Pharma in her DNA, Wockhardt scion ready for deep dive in the USZahabiya Khorakiwala is leading Wockhardt's US business and the launch of its new antibiotic, Zaynich. This drug targets resistant bacteria...- If you have the patience, you can achieve innovation milestones, says Wockhardt chairman Habil KhorakiwalaWockhardt Hospitals is set to launch its antibiotic Zaynich in the US. Zahabiya Khorakiwala will lead US operations. The drug is expected t...
- Wockhardt secures US FDA approval for antibiotic ZaynichWockhardt's novel antibiotic, Zaynich (cefepime and zidebactam), has received US FDA approval for complicated urinary tract infections. Thi...
- Wockhardt raises Rs 480 crore to pare debt, fund drug trialWockhardt plans to clear debt, fund antibiotic trials with QIP funds. Khorakiwala expects revenue growth, EBITDA rise, and completion of gl...
- Wockhardt sets up its first manufacturing facility in Middle East"With the new facility in the Middle East, we aim to focus on our commitment to developing NCEs to fight the health issues," Wockhardt Foun...
- Sell Wockhardt, target Rs 705: Manas JaiswalSell Wockhardt Ltd. at a price target of Rs 705.0 and a stop loss at Rs 741 from entry point.
- Buy Wockhardt, target Rs 880: Kunal BothraBuy Wockhardt Ltd. at a price target of Rs 880.0 and a stop loss at Rs 800 from entry point.
- Buy Wockhardt, target Rs 840: Dr CK NarayanBuy Wockhardt Ltd. at a price target of Rs 840.0 and a stop loss at Rs 810 from entry point.
- Buy Wockhardt, target Rs 795: Shrikant ChouhanBuy Wockhardt Ltd. at a price target of Rs 795.0 and a stop loss at Rs 750 from entry point.
- Buy Wockhardt, target Rs 985: Shrikant ChouhanBuy Wockhardt Ltd. at a price target of Rs 985.0 and a stop loss at Rs 940 from entry point.
- Buy Wockhardt, target Rs 850: Kunal BothraBuy Wockhardt Ltd. at a price target of Rs 850.0 and a stop loss at Rs 795 from entry point.
- Buy Wockhardt, target Rs 800: Dr CK NarayanBuy Wockhardt Ltd. at a price target of Rs 800.0 and a stop loss at Rs 775 from entry point.
- Buy Wockhardt, target Rs 775: Dr CK NarayanBuy Wockhardt Ltd. at a price target of Rs 775.0 and a stop loss at Rs 750 from entry point.
- Buy Wockhardt, target Rs 825: Kunal BothraBuy Wockhardt at a price target of Rs 825.0 and a stop loss at Rs 725 from entry point.
- Buy Wockhardt, target Rs 770: Dr CK NarayanBuy Wockhardt at a price target of Rs 770 and a stop loss at Rs 745 from entry point.
- Fortis Healthcare in deal talks to take control of Wockhardt HospitalsFortis is extremely keen to expand its footprint in the hospital sector in India and the Wockhardt Hospitals network has 9 hospitals.
- Wockhardt: Will investors forgive the company?Forget its financial and legal woes, Habil Khorakiwala wants the world to notice that Wockhardt is on the road to recovery.
- Investors unwilling to forgive Wockhardt, promoter for failingsForget its financial and legal woes, Habil Khorakiwala wants the world to notice that Wockhardt is on the road to recovery.
- Wockhardt won't sell head-office in Mumbai: DirectorPharma major, Wockhardt on Friday said that it was looking at raising funds and was evaluating various options but selling its head-office,...
- Murtaza’s elevation to top post at Wockhardt strengthens gripWockhardt chairman and managing director Habil Khorakiwala’s move to step down from the post of MD and appoint younger son Murtaza Khorakiw...
Load More
